Latest Market Data
Refresh
Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

FRONTAGE HOLDINGS CORPORATION (1521)

FRONTAGE (1521)

HK$1.600

+0.220 (+15.94%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$1.380
Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$1.490
TURNOVER
HK$4.54M
VOLUME
2.77M
MKT CAP
HK$3.25B
LOT SIZE
2,000
BID
HK$1.600
ASK
HK$1.630
EPS
US$0.0004
P/E
516.13x
DIV YIELD
-
INTRA-DAY 52W
High HK$1.740 HK$1.830
Low HK$1.470 HK$0.470
Information is available after the market opens and is delayed by at least 15 minutes.
Updated: 23 Jul 2025 16:08 HKT
  • 1 D
  • 1 M
  • 3 M
  • 6 M
  • YTD
  • 1 Y
  • 2 Y
  • 5 Y
  • 10 Y
1min
5min
15min
Hourly
Created with Highstock 6.2.00.0001.0001.2001.4001.6001.8000120K240K10:0011:0012:0013:0014:0015:0016:00Prev. Close
1.380
All charts use the last traded price or closing price.

COMPANY PROFILE

Frontage Holdings Corporation is a holding company. It provides laboratory and related services to pharmaceutical and agrochemical companies, as well as bioequivalence clinical and chemical services. The Company has two main divisions: Global Laboratory Services and Global Drug Discovery & Development Services. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. The Global Drug Discovery & Development Services division includes Drug Development Unit, the Drug Discovery Unit, and the Pharmaceutical Product Development Unit. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Drug Development Unit includes drug metabolism and pharmacokinetics, Safety and Toxicology. The Company's segments include North America and Europe and PRC. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares) 2,035,724,910 (as at 30 Jun 2025)
Industry Healthcare - Pharmaceuticals & Biotechnology - Biotechnology Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Listing Date 30 May 2019
Financial Year Ends 31 Dec 2024
Chairman Li Song
Principal Office Room 1920, 19/F
Lee Garden One
33 Hysan Avenue
Causeway Bay, Hong Kong
Place of Incorporation Cayman Islands
Listing Category Primary Listing

a. Updating time-lag
The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.
b. Rights issues or bonus issues
The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.
c. Share splits or share consolidations
The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.
d. Conversion of convertible notes into shares
If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.
Updated: 23 Jul 2025 18:39 HKT
* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced Ex-Date Details Financial Year End Book Close Date Payment date may be indicative only.Payment Date
27 Mar 2025-No Dividend for the period ended
2024/12/31
31 Dec 2024--
28 Aug 2024-No Dividend for the period ended
2024/06/30
31 Dec 2024--
28 Mar 2024-No Dividend for the period ended
2023/12/31
31 Dec 2023--
25 Aug 2023-No Dividend for the period ended
2023/06/30
31 Dec 2023--
28 Mar 2023-No Dividend for the period ended
2022/12/31
31 Dec 2022--
LOAD MORE
Updated: 23 Jul 2025 01:15 HKT
Dividend details are sourced from Announcement Forms published on HKEXnews